Jeffrey Etter

Title: Jeffrey Etter: Innovator in Pharmaceutical and Ocular Technologies

Introduction

Jeffrey Etter is an accomplished inventor based in the United States. He has made significant contributions to the fields of pharmaceuticals and ocular technology. Despite having no patents registered under his name, his innovative work has led to the development of groundbreaking inventions.

Latest Patents

One of Jeffrey Etter's notable inventions is the "High Dosage Strength Tablets of Rucaparib." This invention discloses a tablet that includes a high dosage of 8-fluoro-2-(4-[(methylamino)methyl]phenyl)-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one camsylate salt. The invention is directed towards high dosage strength tablets of rucaparib, with some embodiments containing 45-90% w/w rucaparib camsylate. For instance, one embodiment features a tablet containing at least 200 mg of rucaparib, while another contains at least 300 mg. This invention also relates to the use of the tablet in treating mammalian diseases mediated by poly(ADP-ribose) polymerase activity, including cancer.

Another significant invention by Etter is the "Methods and Apparatus for Delivery of Ocular Implants." This invention pertains to an apparatus designed for implanting an ocular implant in a patient's eye. The apparatus consists of a cannula with a lumen extending through it, configured to receive an ocular implant. It also includes features to minimize the inadvertent release of the implant from the cannula.

Career Highlights

Throughout his career, Jeffrey Etter has worked on various innovative projects that have contributed to advancements in medical technology. His work has focused on creating effective solutions for complex medical challenges.

Collaborations

Jeffrey has collaborated with notable professionals in his field, including David Weber and Ingrid Kane. These collaborations have enriched his work and expanded the impact of his inventions.

Conclusion

Jeffrey Etter is a dedicated inventor whose work in pharmaceuticals and ocular technology showcases his commitment to innovation. His contributions, particularly in the development of high dosage strength tablets and ocular implant delivery systems, highlight his role in advancing medical solutions.